Enhancing the peripheral chemoreflex to protect the newborn against hypoxic injury – A translational study based on fetal sheep model of birth asphyxia
Bidragets beskrivning
Severe birth asphyxia is a major cause of newborn mortality and in survivors birth asphyxia can cause life-long consequences that can manifest as neurologic morbidities. Birth asphyxia implies a decrease in systemic oxygenation and accumulation of pCO2 in fetal circulation. Typically during labor birth asphyxia develops if reperfusion time between uterine contractions is inadequate or placental function is suboptimal. If the newborn suffers from birth asphyxia, therapeutic hypothermia is the treatment of choice. In this study, we propose a new treatment to minimize the asphyxia-related brain abnormalities and improve long-term neurologic outcome. We test whether acetazolamide medication when given to the asphyxiated newborn will improve outcome. Studies on rats and mice have shown that acetazolamide significantly improves tissue oxygenation and inhibits seizure activity. We use fetal sheep model to test, if this drug can prevent newborn short- and long-term neurologic problems.
Visa merStartår
2021
Slutår
2023
Beviljade finansiering
Övriga uppgifter
Finansieringsbeslutets nummer
342826
Vetenskapsområden
Genetik, utvecklingsbiologi, fysiologi
Forskningsområden
Kehitysbiologia ja fysiologia
Identifierade teman
gynecology, pediatrics